AAAAAA

   
Results: 1-16 |
Results: 16

Authors: BERGQVIST D TROENG T ELFSTROM J HEDBERG B LJUNGSTROM KG NORGREN L ORTENWALL P
Citation: D. Bergqvist et al., AUDITING SURGICAL OUTCOME - 10 YEARS WITH THE SWEDISH VASCULAR REGISTRY - SWEDVASC, The European journal of surgery, 164, 1998, pp. 3-48

Authors: BERGQVIST D ELFSTROM J HEDBERG B LJUNGSTROM KG NORGREN L TROENG T ORTENWALL P
Citation: D. Bergqvist et al., REOPERATIONS, REDO SURGERY AND OTHER INTERVENTIONS CONSTITUTE MORE THAN 1 3 OF VASCULAR-SURGERY - A STUDY FROM SWEDVASC (THE SWEDISH-VASCULAR-REGISTRY)/, European journal of vascular and endovascular surgery, 14(4), 1997, pp. 244-251

Authors: HEDIN H LJUNGSTROM KG
Citation: H. Hedin et Kg. Ljungstrom, PREVENTION OF DEXTRAN ANAPHYLAXIS - 10 YEARS EXPERIENCE WITH HAPTEN DEXTRAN, International archives of allergy and immunology, 113(1-3), 1997, pp. 358-359

Authors: ERIKSSON S BACKMAN L LJUNGSTROM KG
Citation: S. Eriksson et al., THE INCIDENCE OF CLINICAL POSTOPERATIVE THROMBOSIS AFTER GASTRIC-SURGERY FOR OBESITY DURING 16 YEARS, Obesity surgery, 7(4), 1997, pp. 332-335

Authors: FLORDAL PA BERGQVIST D BURMARK US LJUNGSTROM KG TORNGREN S
Citation: Pa. Flordal et al., RISK-FACTORS FOR MAJOR THROMBOEMBOLISM AND BLEEDING TENDENCY AFTER ELECTIVE GENERAL SURGICAL OPERATIONS, The European journal of surgery, 162(10), 1996, pp. 783-789

Authors: BERGQVIST D FLORDAL PA FRIBERG B FRISELL J HEDBERG M LJUNGSTROM KG MATZSCH T TORNGREN S
Citation: D. Bergqvist et al., THROMBOPROPHYLAXIS WITH A LOW-MOLECULAR-WEIGHT HEPARIN (TINZAPARIN) IN EMERGENCY ABDOMINAL-SURGERY - A DOUBLE-BLIND MULTICENTER TRIAL, VASA, 25(2), 1996, pp. 156-160

Authors: TROENG T BERGQVIST D ELFSTROM J HEDBERG B LJUNGSTROM KG ORTENWALL P NORGREN L
Citation: T. Troeng et al., OUTCOME ASSESSMENT IN VASCULAR-SURGERY - THE SWEDISH EXPERIENCE, Journal of vascular surgery, 22(6), 1995, pp. 810-811

Authors: FLORDAI PA BERGQVIST D LJUNGSTROM KG TORNGREN S
Citation: Pa. Flordai et al., DOES A POSITIVE I-125 FIBRINOGEN UPTAKE TEST PREDICT THE RISK TO DEVELOP MAJOR VENOUS THROMBOEMBOLISM OR TO DIE AFTER ELECTIVE GENERAL ABDOMINAL-SURGERY, Thrombosis and haemostasis, 73(6), 1995, pp. 962-962

Authors: FLORDAL PA BERGQVIST D BURMARK US LJUNGSTROM KG TORNGREN S
Citation: Pa. Flordal et al., MAJOR THROMBOEMBOLISM AND DIFFUSE BLEEDING AFTER ELECTIVE GENERAL ABDOMINAL-SURGERY - CLINICAL RISK-FACTORS, Thrombosis and haemostasis, 73(6), 1995, pp. 1096-1096

Authors: FLORDAL PA BERGQVIST D LJUNGSTROM KG TORNGREN S
Citation: Pa. Flordal et al., CLINICAL RELEVANCE OF THE FIBRINOGEN UPTAKE TEST IN PATIENTS UNDERGOING ELECTIVE GENERAL ABDOMINAL-SURGERY - RELATION TO MAJOR THROMBOEMBOLISM AND MORTALITY, Thrombosis research, 80(6), 1995, pp. 491-497

Authors: FLORDAL PA LJUNGSTROM KG
Citation: Pa. Flordal et Kg. Ljungstrom, DEXTRAN EXCRETION RATE IN DESMOPRESSIN TREATED VOLUNTEERS, Thrombosis research, 79(1), 1995, pp. 131-134

Authors: BERGQVIST D BURMARK US FLORDAL PA FRISELL J HALLBOOK T HEDBERG M HORN A KELTY E KVITTING P LINDHAGEN A LJUNGSTROM KG MATZSCH T RISBERG B SYK I TORNGREN S WELLANDER E ORTENWALL P
Citation: D. Bergqvist et al., LOW-MOLECULAR-WEIGHT HEPARIN STARTED BEFORE SURGERY AS PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS - 2500 VERSUS 5000 XAI UNITS IN 2070 PATIENTS, British Journal of Surgery, 82(4), 1995, pp. 496-501

Authors: LJUNGSTROM KG
Citation: Kg. Ljungstrom, HAPTEN INHIBITION OF DEXTRAN REACTIONS - 10 YEARS EXPERIENCE WITH DEXTRAN-1, British Journal of Anaesthesia, 74, 1995, pp. 127-127

Authors: LJUNGSTROM KG
Citation: Kg. Ljungstrom, SAFETY OF DEXTRAN IN RELATION TO OTHER COLLOIDS - 10 YEARS EXPERIENCEWITH HAPTEN INHIBITION, Infusionstherapie und Transfusionsmedizin, 20(5), 1993, pp. 206-210

Authors: LJUNGSTROM KG WILLMAN B HEDIN H
Citation: Kg. Ljungstrom et al., HAPTEN INHIBITION OF DEXTRAN ANAPHYLAXIS - 9 YEARS OF POSTMARKETING SURVEILLANCE OF DEXTRAN-1, Annales francaises d'anesthesie et de reanimation, 12(2), 1993, pp. 219-222

Authors: BURMARK BD ESKILSSON C FLORDAL PA FRISELL J HALLBOOK T HEDBERG M HORN A KVITTING P LINDHAGEN A LJUNGSTROM KG MATZSCH T RISBERG B SYK I TORNGREN S WELLANDER E ORTENWALL P
Citation: Bd. Burmark et al., LOW-MOLECULAR-WEIGHT HEPARIN (DALTEPARIN) STARTED IN THE EVENING BEFORE SURGERY AS PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS - 2500 COMPAREDWITH 5000 XAI UNITS IN 2097 PATIENTS, Thrombosis and haemostasis, 69(6), 1993, pp. 545-545
Risultati: 1-16 |